Clinical trial
(+)-Alpha-Dihydrotetrabenazine Phase I
NCT02844179 is registered in ClinicalTrials.gov with Kirk A. Frey as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- (+)-Alpha-Dihydrotetrabenazine Phase I
- Lead sponsor
- Kirk A. Frey
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2016
- Completion date
- June 27, 2017
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy subjects